Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Submitted by
admin
on May 11, 2017 - 11:21am
Source:
Endpoints
News Tags:
Pfizer
gene therapy
hemophilia
Sangamo BioSciences
SB-525
hemophilia A
Headline:
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Do Not Allow Advertisers to Use My Personal information
